MiR-29c-3p Targets KDM5B to Suppress ESCC Progression and Enhance Anti-PD-L1-Related Immune Activation <i>In Vitro</i>
BIOCELL · Xiaobiao Ma, Jiamin Liu, Dan Liu et al. · 2026
- EnglishRead in your language
- CitedEvery fact sourced
- Ad-freeNo ads, no tracking
Quick facts
Questions
- Who wrote MiR-29c-3p Targets KDM5B to Suppress ESCC Progression and Enhance Anti-PD-L1-Related Immune Activation <i>In Vitro</i>?
- MiR-29c-3p Targets KDM5B to Suppress ESCC Progression and Enhance Anti-PD-L1-Related Immune Activation <i>In Vitro</i> was written by Xiaobiao Ma, Jiamin Liu, Dan Liu, Yongjiang Yao.
- When was MiR-29c-3p Targets KDM5B to Suppress ESCC Progression and Enhance Anti-PD-L1-Related Immune Activation <i>In Vitro</i> first published?
- MiR-29c-3p Targets KDM5B to Suppress ESCC Progression and Enhance Anti-PD-L1-Related Immune Activation <i>In Vitro</i> was first published in 2026.
Sources
Last updated · facts checked 16 October 2026
Cite this page
"MiR-29c-3p Targets KDM5B to Suppress ESCC Progression and Enhance Anti-PD-L1-Related Immune Activation <i>In Vitro</i>". DigiNepal. Last updated 16 October 2026. https://diginpl.com/books/paper-biocell-2026-087405. Retrieved 14 November 2026.
Open-access publication. Read it free at the publisher: https://doi.org/10.32604/biocell.2026.087405.